These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1036757

  • 1. [Relation between citicoline and pulmonary surfactant. Recent acquisitions in the treatment of respiratory syndromes of the newborn].
    Colombo ML, Dogliani P, Raggi M.
    Minerva Pediatr; 1976 Nov 24; 28(37):2303-10. PubMed ID: 1036757
    [No Abstract] [Full Text] [Related]

  • 2. [Study of fetal alveolar surfactant: possibility of induction].
    Bracaglia R, Bellati U, Serri F, Garzetti GG.
    Clin Ter; 1979 Dec 31; 91(6):593-606. PubMed ID: 44494
    [No Abstract] [Full Text] [Related]

  • 3. [The place of citicolin in pulmonological therapy (author's transl)].
    Cornia G, Gramiccioni E.
    MMW Munch Med Wochenschr; 1976 Jun 18; 118(25):817-8. PubMed ID: 819809
    [Abstract] [Full Text] [Related]

  • 4. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome].
    Valls i Soler A, Sanjurjo P, Vázquez Cordero C.
    An Esp Pediatr; 1988 Jun 18; 28(6):493-6. PubMed ID: 3195851
    [Abstract] [Full Text] [Related]

  • 5. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O, Kale G.
    Pathol Res Pract; 2009 Jun 18; 205(1):35-41. PubMed ID: 18951732
    [Abstract] [Full Text] [Related]

  • 6. [Position of cyticholine in pneumologic therapy].
    Cornia G, Gramiccioni E.
    Minerva Med; 1975 Nov 14; 66(77):4053-5. PubMed ID: 1041758
    [Abstract] [Full Text] [Related]

  • 7. [Alveolar surfactant and experimental diabetes (protective action of citicoline)].
    Iozzo A, Cardellino G, Dalmasso F, Garbagni R.
    Arch Sci Med (Torino); 1978 Nov 14; 135(2):181-6. PubMed ID: 581158
    [Abstract] [Full Text] [Related]

  • 8. [Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis].
    Pacheco Y, Douss T, Pujol B, Revol A, Vergnon JM, Biot N, Brune J, Perrin-Fayolle M.
    Rev Pneumol Clin; 1985 Nov 14; 41(2):91-100. PubMed ID: 3839593
    [Abstract] [Full Text] [Related]

  • 9. [Increased production of alveolar surfactant in the human fetus after treatment with cytidine diphosphocholine].
    Bracaglia R, Bellati U, Buscemi L, Riccardi P, Garzetti GG, Liverani A.
    Clin Ter; 1977 Dec 15; 83(5):531-9. PubMed ID: 580231
    [No Abstract] [Full Text] [Related]

  • 10. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].
    Silberg IE, Grønn M.
    Tidsskr Nor Laegeforen; 1997 Apr 20; 117(10):1456-8. PubMed ID: 9198922
    [Abstract] [Full Text] [Related]

  • 11. [The relation between the gastric aspirate foam test and pulmonary maturity in the newborn infant].
    colombo ML, Dogliani P, Raggi M.
    Minerva Pediatr; 1980 Jan 15; 32(1):1-6. PubMed ID: 6894779
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical basis of hyaline membrane disease.
    Forman DT.
    Ann Clin Lab Sci; 1973 Jan 15; 3(4):242-8. PubMed ID: 4740424
    [No Abstract] [Full Text] [Related]

  • 13. [Pulmonary surfactants].
    Pariente R, André-Bougaran J, Legrand M, Cayrol E, Leturcq E.
    Pathol Biol (Paris); 1973 Feb 15; 21(2):197-208. PubMed ID: 4266994
    [No Abstract] [Full Text] [Related]

  • 14. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1977 Dec 15; 52(12):1413-7. PubMed ID: 343058
    [No Abstract] [Full Text] [Related]

  • 15. [Pulmonary surfactant].
    Murakami K, Ono K, Fujiwara T, Sawada H, Mori I.
    Nihon Ishikai Zasshi; 1971 Jul 01; 66(1):100-16. PubMed ID: 4254974
    [No Abstract] [Full Text] [Related]

  • 16. [Syndrome caused by surfactant deficiency and ventilatory dysfunction in the newborn infant. Clinico-radiological diagnostic problems].
    Bona G, Italiano F, Ardissone P.
    Minerva Pediatr; 1981 Feb 15; 33(3):117-26. PubMed ID: 6894628
    [No Abstract] [Full Text] [Related]

  • 17. [Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
    Keuth U.
    Fortschr Med; 1973 Jun 07; 91(16):693-7. PubMed ID: 4740218
    [No Abstract] [Full Text] [Related]

  • 18. [Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
    Ji SP, Zhang XL, Ma WX, Sun YP, Li XH, Yu JH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr 07; 19(4):248. PubMed ID: 17448287
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of respiratory distress syndrome. Sodium bicarbonate and glucose solution.
    Blumberg ML.
    N Y State J Med; 1969 Oct 01; 69(19):2549-55. PubMed ID: 5259240
    [No Abstract] [Full Text] [Related]

  • 20. [Pulmonary surfactant: anti-atelectasis factor].
    Ouellet Y.
    Laval Med; 1970 May 01; 41(5):627-30. PubMed ID: 4928481
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.